Key result
Daily taVNS linked to a 9-point coma recovery score increase in one patient.
Why the study?
Neuromodulatory electroceuticals such as vagus nerve stimulation are emerging as potential rehabilitation tools for disorders of consciousness but require further longitudinal evaluation.
Does transcutaneous auricular vagus nerve stimulation improve behavioral and electrophysiological outcomes in a patient with chronic unresponsive wakefulness syndrome?
Case Report (n=1)
No
Does transcutaneous auricular vagus nerve stimulation improve behavioral and electrophysiological outcomes in a patient with chronic unresponsive wakefulness syndrome?
Longitudinal taVNS in a patient with chronic unresponsive wakefulness syndrome was associated with transient behavioral improvements and favorable shifts in autonomic and cortical electrophysiological markers.
Answers are grounded in this paper and cite their sources.
taVNS-linked CRS-R gains in one case are hypothesis-generating; controlled trials needed before any clinical consideration in unresponsive wakefulness syndrome.
Neuromodulatory electroceuticals such as vagus nerve stimulation have been recently gaining traction as potential rehabilitation tools for disorders of consciousness (DoC). We present a longitudinal case study of non-invasive auricular vagus nerve stimulation (taVNS) in a patient diagnosed with chronic unresponsive wakefulness syndrome (previously known as vegetative state). Over a period of 6 months we applied taVNS daily and regularly evaluated the patient's behavioral outcomes using Coma Recovery Scale - Revised. We also took electrophysiological measures: resting state electroencephalography (EEG), heart rate (HR) and heart rate variability (HRV). All these methods revealed signs of improvement in the patient's condition. The total CRS-R scores fluctuated but rose from 4 and 6 at initial stages to the heights of 12 and 13 in the 3rd and 5th month, which would warrant a change in diagnosis to a Minimally Conscious State. Scores obtained in a 2 months follow-up period, though, suggest this may not have been a lasting improvement. Behavioral signs of recovery are triangulated by EEG frequency spectrum profiles with re-emergence of a second oscillatory peak in the alpha range, which has been shown to characterize aware people. However, sustained spontaneous theta oscillations did not predictably diminish, which most likely reflects structural brain damage. ECG measures revealed a steady decrease in pre-stimulation HR combined with an increase in HRV-HR. This suggests a gradual withdrawal of sympathetic and an increase in parasympathetic control of the heart, which the previous literature has also linked with DoC improvements. Together, this study suggests that taVNS stimulation holds promise as a DoC treatment.
No takes yet. Share an insight, caveat, or question.
Osińska et al. (2022) conducted a case report in Unresponsive wakefulness syndrome (n=1). Transcutaneous auricular vagus nerve stimulation (taVNS) vs. Baseline was evaluated on Coma Recovery Scale - Revised (CRS-R) total score. Daily transcutaneous auricular vagus nerve stimulation over 6 months increased the patient's Coma Recovery Scale-Revised score from a baseline of 4 to a peak of 13, suggesting a transition to a Minimally Conscious State.
Synapse has enriched 10 related papers. Consider them for comparative context: